The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis
Open accessAbstract
Background & aims Norfloxacin is highly effective in preventing spontaneous bacterial peritonitis recurrence in cirrhosis, but its role in the primary prevention of this complication is uncertain.Methods Patients with cirrhosis and low protein ascitic levels (<15 g/L) with advanced liver failure (Child-Pugh score > or = 9 points with serum bilirubin level > or = 3 mg/dL) or impaired renal function (serum creatinine level > or = 1.2 mg/dL, blood urea nitrogen level > or = 25 mg/dL, or serum sodium level < or = 130 mEq/L) were included in a randomized controlled trial aimed at comparing norfloxacin (35 patients) vs placebo (33 patients) in the primary prophylaxis of spontaneous bacterial peritonitis. The main end points of the trial were 3-month and 1-year probability of survival. Secondary end points were 1-year probability of development of spontaneous bacterial peritonitis and hepatorenal syndrome.Results Norfloxacin administration reduced the 1-year probability of developing spontaneous bacterial peritonitis (7% vs 61%, P < .001) and hepatorenal syndrome (28% vs 41%, P = .02), and improved the 3-month (94% vs 62%, P = .003) and the 1-year (60% vs 48%, P = .05) probability of survival compared with placebo.Conclusions Primary prophylaxis with norfloxacin has a great impact in the clinical course of patients with advanced cirrhosis. It reduces the incidence of spontaneous bacterial peritonitis, delays the development of hepatorenal syndrome, and improves survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to norfloxacin, rifaximin has been noted to increased survival in patients with advanced liver cirrhosis in several small-scale trials92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Moreover, several small-scale clinical studies have suggested that antibiotics such as norfloxacin and rifaximin increase survival in patients with liver cirrhosis92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
Arroyo, V., Ginès, P., Gerbes, A. L., Dudley, F. J., Geñtilini, P., Laffi, G., Reynolds, T. B., Ring‐Larsen, H., & Schölmerich, J. (1996) · Hepatology · doi:10.1002/hep.510230122 · Cited by 1,694
Self-citationSort, P., Navasa, M., Arroyo, V., Aldeguer, X., Planas, R., Ruíz-del-Árbol, L., Castells, L., Vargas, V., Soriano, G., Guevara, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410603 · Cited by 1,636
Self-citationDiagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
Rimola, A., García–Tsao, G., Navasa, M., Piddock, L. J. V., Planas, R., Bernard‐Chabert, B., & Inadomi, J. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80201-9 · Cited by 1,058
Self-citationFernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30082 · Cited by 954
Self-citationIncidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
Ginés, À., Escorsell, À., Ginès, P., Saló, J., Jiménez, W., Inglada, L., Navasa, M., Clària, J., Rimola, A., Arroyo, V., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90031-7 · Cited by 874
Self-citationGinés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Self-citationFollo, A., Llovet, J. M., Navasa, M., Planas, R., Forns, X., Francitorra, A., Rimola, A., Gassull, M. A., Arroyo, V., & Rodés, J. (1994) · Hepatology · doi:10.1002/hep.1840200619 · Cited by 597
Self-citationCirculatory function and hepatorenal syndrome in cirrhosis†
Ruíz-del-Árbol, L., Monescillo, A., Arocena, C., Valer, P., Ginès, P., Moreira, V., Milicua, J. M., Jiménez, W., & Arroyo, V. (2005) · Hepatology · doi:10.1002/hep.20766 · Cited by 584
Self-citationRuíz-del-Árbol, L., Urmán, J., Fernández, J., González, M., Navasa, M., Monescillo, A., Albillos, A., Jiménez, W., & Arroyo, V. (2003) · Hepatology · doi:10.1053/jhep.2003.50447 · Cited by 496
Self-citationLlach, J., Ginès, P., Arroyo, V., Rimola, A., Titó, L., Badalamenti, S., Jiménez, W., Gaya, J., Rivera, F., & Rodés, J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90441-6 · Cited by 457
Self-citation
Flagged first, then by citations
2 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 709
Inflammatory Biomarkers in Ascites
Lutz, P. L., Nischalke, H. D., & Spengler, U. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7675-3_3 · Cited by 2
Wu, C., & Tseng, C. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_5 · Cited by 2
Coxeter-Smith, C., Al-Adhami, A., & Alrubaiy, L. (2023) · Cureus · doi:10.7759/cureus.38343 · Cited by 2
García–Tsao, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00015-x · Cited by 2
Ascitis y s?ndrome hepatorrenal en la cirrosis hep?tica
Gonzlez-Alonso, R., Crespo, L., Garca-Aguilera, X., & Martnez, A. A. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73140-0 · Cited by 2
Reply to: “Prophylaxis of spontaneous bacterial peritonitis: is there still room for quinolones?”
Angeli, P., & Bernardi, M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.011 · Cited by 2
Spontaneous Bacterial Peritonitis: The Bug Matters
Sandhu, S., & John, B. V. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-07865-w · Cited by 2
Hepatic Ascites in Liver Cirrhosis
Kawaratani, H., & Yoshiji, H. (2019) · Springer eBooks · doi:10.1007/978-981-13-7979-6_9 · Cited by 1
Lia, D., & Grodstein, E. I. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.01.004 · Cited by 1
Risk Factors Recurrence of Spontaneous Ascitic Fluid Infection (Slai) in Cirrhotic Patients
Sarifou, D. M., Lionel, O. O. C., Dramane, S., Oumarou, Y., Yaogo, A., & Jeanne, L.-K. M. (2024) · Open Journal of Gastroenterology · doi:10.4236/ojgas.2024.148028 · Cited by 1
Albillos, A., Bañares, R., & Hernández–Gea, V. (2024) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2024.10805/2024 · Cited by 1
Insuficiencia renal en la cirrosis hepática
Solà, E., & Ginès, P. (2011) · Gastroenterología y Hepatología · Cited by 1
Self-citationMoreau, R. (2012) · Réanimation · doi:10.1007/s13546-012-0536-z · Cited by 1
The burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with cirrhosis
Moreau, R. (2014) · Hepatology International · doi:10.1007/s12072-014-9567-z · Cited by 1
Profilaxis y tratamiento de la peritonitis bacteriana espontánea en el paciente cirrótico
Barreales, M., Muñoz, R., & Fernández, I. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70366-9 · Cited by 1
Role of Infections in Hepatorenal Syndrome
Wiest, R. (2011) · Frontiers of gastrointestinal research · doi:10.1159/000319035 · Cited by 2
Drug therapies in liver disease
Collins, P. L., Ayres, L., & Valliani, T. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-6-585 · Cited by 1
Clinical trials and their translation in hepatology: Past, present, and future
Heathcote, J. (2011) · Hepatology · doi:10.1002/hep.25557 · Cited by 1
Peritonite bacteriana espontânea: novas perspectivas
Guedes, R. R., Kieling, C. O., Matte, Ú. D. S., & Vieira, S. M. G. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Ascitis, insuficiencia renal aguda y encefalopatía hepática
García‐Martínez, R. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.05.012 · Cited by 1
Moreau, R. (2013) · Cited by 1
Spontaneous Bacterial Peritonitis: Is It Still A Life-Threatening Issue in Cirrhosis?
Ribeiro, T. C. D. R. (2016) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2016.05.616 · Cited by 1
Acute Kidney Injury in Liver Disease
Deep, A., & Saxena, R. (2018) · Springer eBooks · doi:10.1007/978-3-319-90281-4_10 · Cited by 1
Main Complications of AECHB and Severe Hepatitis B (Liver Failure)
Song, J., Zhu, L., Zhu, C., Hu, J., Sun, Z., Xu, X., Xin, M.-Y., Zhang, Q., Zhang, D., Shang, J., et al. (2019) · Springer eBooks · doi:10.1007/978-94-024-1603-9_2 · Cited by 1
Angeli, P. (2019) · Hepatology International · doi:10.1007/s12072-019-09961-4 · Cited by 1
Fernández, J., & Arroyo, V. (2020) · doi:10.1093/med/9780198746690.003.0318 · Cited by 1
Self-citationComplicaciones de la cirrosis hepática
Llerena, S., Cuadrado, A., de Lope, C. R., & Crespo, J. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.04.003 · Cited by 1
García–Tsao, G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00018-8 · Cited by 1
Sangroongruangsri, S., Kittrongsiri, K., Charatcharoenwitthaya, P., Sobhonslidsuk, A., & Chaikledkaew, U. (2021) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s317390 · Cited by 1
Canbay, A. E., Witzke, O., & Gerken, G. (2010) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-010-0192-3 · Cited by 1
Translocation of gut microbiota in liver cirrhosis: mechanisms, clinical significance, and markers
Гавриленко, Д. И., & Силивончик, Н. Н. (2021) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2021.2.147-160 · Cited by 1
Gordon, C. E. (2011) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2011.11.003 · Cited by 1
Allah, A.-N. A.-A. G., Abbas, R. E., Dala, A. G., Ramadan, S. E., & Elbasuony, H. A. A. (2023) · Surgery Gastroenterology and Oncology · doi:10.21614/sgo-514 · Cited by 1
SPONTANEOUS BACTERIAL PERITONITIS PROFILE IN DECOMPENSATED CIRRHOTIC EGYPTIAN PATIENTS
SEBAWEH, S., Hamdy, H., Balakosy, A. A., Hussein, H. M., Hassan, M. Y., & Khedr, L. E. (2023) · Journal of the Egyptian Society of Parasitology · doi:10.21608/jesp.2023.297343 · Cited by 1
Tagliaferri, A. R., Ansari, N., Melki, G., & Cavanagh, Y. (2024) · GastroHep · doi:10.1155/2024/9271718 · Cited by 1
Spontaneous Bacterial Peritonitis
Stojan, J., & Lukela, M. P. (2014) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2014.03.003 · Cited by 1
Predictors of outcomes in patients with ascites, hyponatremia, and renal failure
Asrani, S. K., & Kamath, P. S. (2013) · Clinical Liver Disease · doi:10.1002/cld.203 · Cited by 1
Jurnalis, Y. D., Sayoeti, Y., & Julinar, J. (2012) · Jurnal Kesehatan Andalas · doi:10.25077/jka.v1i3.88 · Cited by 1
Ascites: Treatment, Complications, and Prognosis
Huelin, P., Fortea, J. I., Crespo, J., & Fábrega, E. (2017) · InTech eBooks · doi:10.5772/intechopen.70384 · Cited by 1
Bacterial Infections in Patients with Cirrhosis
Gustot, T., & Moreau, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-13614-1_24 · Cited by 1
Hepatorenal Syndrome: Update on pathogenesis and management
Nasser, M., Elgamal, H., Ahmed, E. E., Soliman, R., & Awad, M. (2018) · Medical Journal of Viral Hepatitis /Medical Journal of Viral Hepatitis · doi:10.21608/mjvh.2018.55735 · Cited by 1
Graupera, I., Solà, E., & Ginès, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00038-2 · Cited by 1
Self-citationCritical Care Management of Patients With Liver Disease
Factor, P. H., & Saab, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00013-6 · Cited by 1
Wong, F. S.-H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00017-3 · Cited by 1
Kamila, S., Gurunath, S., Srinivas, N. S., Babu, S., Abhiman, G., Ushasri, R., Syed, T. W., Salunke, S., & Komittishetty, S. (2020) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2020.00003 · Cited by 1
The Treatment of Bacterial and Parasitic Diseases of the Liver
Rombaoa, C., & Hu, K. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_14 · Cited by 1
El-Gebaly, A., Ghanem, N. S., & Abdelmoaty, A. A. (2021) · Zagazig University Medical Journal · doi:10.21608/zumj.2021.57979.2083 · Cited by 1
Kiser, T. H. (2014) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2014.53018 · Cited by 1
Faust, N. W., Yamada, A., Haider, H., Komaki, Y., Komaki, F., Micić, D., & Sakuraba, A. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i5.229 · Cited by 1
Spontaneous bacterial peritonitis — A disease of the gut? Therapeutic implications
Fernández, J., Cárdenas, A., & Ginès, P. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8656-4_25 · Cited by 1
Self-citationHepatorenal Syndrome and Other Liver-Related Kidney Diseases
Wadei, H. M., & Gonwa, T. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47794-9.00030-5 · Cited by 1
Thévenot, T., Blasco, G., Grelat, N., & Pili‐Floury, S. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.07.021 · Cited by 1
Moreau, R., & Lebrec, D. (2008) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2008.05.005 · Cited by 1
Management of Hepatorenal Syndrome
Pépin, M.-N., & Ginès, P. (2008) · Elsevier eBooks · doi:10.1016/b978-141605484-9.50007-1 · Cited by 1
Self-citationThévenot, T. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14544 · Cited by 1
Questions in the design of ANSWER
Rowe, I. A. C., & Parker, R. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32153-6 · Cited by 1
García–Tsao, G. (2011) · Wiley eBooks · doi:10.1002/9781444341294.ch10 · Cited by 1
Infections bactériennes et cirrhose
Silvain, C., & Chagneau-Derrode, C. (2010) · Elsevier eBooks · doi:10.1016/b978-2-8101-0186-3.50009-6
Terlipressin for Hepatorenal Syndrome: The US Experience
Musana, K. A., & Sanyal, A. J. (2011) · Frontiers of gastrointestinal research · doi:10.1159/000319438
Gustot, T., & Moreau, R. (2011) · Frontiers of gastrointestinal research · doi:10.1159/000318992
Innate Immunity in Alcohol Liver Disease
Soares, J.-B., & Pimentel‐Nunes, P. (2012) · InTech eBooks · doi:10.5772/26821
Renal Complications of Liver Disease and the Hepatorenal Syndrome
Wong, F. S.-H. (2011) · doi:10.1002/9781119950509.ch15
Monitoring the Patient Awaiting Liver Transplantation
Geier, A., & Müllhaupt, B. (2012) · doi:10.1002/9781444398441.ch2
Spontaneous Bacterial Peritonitis – Prophylaxis and Treatment
Wiest, R., & Garcia-Tsao, G. (2011) · Frontiers of gastrointestinal research · doi:10.1159/000318963
Müller-Marbach, A., Häussinger, D., Rump, L. C., & Vonend, O. (2010) · Der Nephrologe · doi:10.1007/s11560-009-0339-z
Martín–Llahí, M. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Infecci?n bacteriana en la cirrosis hep?tica
Amors, A., & Such, J. M. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73142-4
Self-citationTratamiento de la insuficiencia hepática crónica hasta el trasplante hepático
Arora, G., & Keeffe, E. B. (2008) · Clínicas médicas de Norteamérica
Testing Beneficial Therapy in Human Cirrhosis Using Animal Models of Cirrhosis
Hoefs, J. C., Morgan, T. R. M., & Ilagan, B. J. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1578-1
Refractory Ascites: How to Establish the Diagnosis and What Can Be Done?
Dharel, N., & Sanyal, A. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0216-8
Hepatitis C and End-stage Liver Disease
Settles, D., & Vinayek, R. (2010) · Current Hepatology Reports · doi:10.1007/s11901-010-0056-0
Jacqmin, S., Ghiglione, S., & Ozier, Y. M. (2009) · Le Praticien en Anesthésie Réanimation · doi:10.1016/j.pratan.2009.07.004
Aszites Diagnostik, Therapie und Sekundärkomplikationen
Sebode, M., & Benten, D. (2012) · Viszeralmedizin · doi:10.1159/000338052
Manejo general y extrahospitalario del paciente con cirrosis
Lpez-Vega, M. C., Lpez-Ortega, S., Cueto, I., & Andrade, R. J. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73143-6
Avances en el tratamiento de la cirrosis hepática. Aplicaciones a la práctica clínica
Pérez, L. C., & Martínez, A. A. (2009) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(09)73030-6
Avances en el tratamiento de la cirrosis hepática
Tejedor, M., & Martínez, A. A. (2010) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(10)70278-x
Acute-on-Chronic Liver Failure: Can We Agree on a Definition?
Simonetto, D. A., & Kamath, P. S. (2015) · Current Hepatology Reports · doi:10.1007/s11901-015-0254-x
Síndrome hepatorenal: patogénesis y tratamiento
Brahm, B. J., & Quera, P. R. (2010) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(10)70577-0
Nerki w przewlekłych chorobach wątroby
Hartleb, M. (2011) · Gastroenterologia Kliniczna. Postępy i Standardy
83-Year-Old Man With Abdominal Swelling and Lower Extremity Edema
Saffouri, G. B., & Wittich, C. M. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.03.008
Cirrosis hepática: medidas preventivas de algunas de sus complicaciones
Toledo, A. (2010) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(10)70597-6
Llopis, S. M. (2013) · TDX (Tesis Doctorals en Xarxa)
Menon, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.004
Alsheikhly, A. S., & Alani, W. S. (2014)
Marik, P. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5923-2_33
Preventing Spontaneous Bacterial Peritonitis in Cirrhotic Patients at High Risk
Zaman, A. (2007) · Journal watch · doi:10.1056/jg200710120000001
Montoliu, S., Ballesté, B., Planas, R., Álvarez, M. A., Rivera, M., Miquel, M., Masnou, H., Cirera, I., Morillas, R. M., Coll, S., et al. (2010)
Self-citationValverde, M., Menéndez, J., & Olivarí, D. (2014)
Infecciones bacterianas en la cirrosis
Martín‐Mateos, R., Mateos, B., Lledó, J. L., Téllez, L., & Albillos, A. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.05.020
Diagnostik und Therapie des hepatorenalen Syndroms
Blomeyer, S., Tyczynski, B., Gerken, G., & Canbay, A. E. (2015) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0041-102647
Perioperative critical care in hepatopancreatobiliary patients
Voigt, L. P., Pastores, S. M., & Halpern, N. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1454-8.00023-0
Renal Failure in Cirrhosis, Hepatorenal Syndrome, and Hyponatremia
Sanyal, A. J., & BOYER, T. D. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00021-8
Infections in Cirrhosis in Critical Care
Preheim, L. C. (2009) · Infectious disease and therapy · doi:10.3109/9781420080049.019
Hepatorenal Syndrome and Other Liver-Related Kidney Diseases
Arroyo, V., Fernández, J., & Jiménez, W. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4617-0.00030-3
Self-citationInflammatory Biomarkers in Ascites
Lutz, P. L., Nischalke, H. D., & Spengler, U. (2015) · Exposure and Health · doi:10.1007/978-94-007-7742-2_3-1
Spontaneous Bacterial Peritonitis (SBP)
Schiro, A. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_31
Mai, M. L., & Wadei, H. M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-0268-8.00032-4
Metadata
- Authors
- Fernández, J., Navasa, M., Planas, R., Montoliu, S., Monfort, D., Soriano, G., Vila, C., Pardo, A., Quintero, E., Vargas, V., Such, J., Ginès, P., & Arroyo, V.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Hospital de Sant Pau (ES)
- Hospital Del Mar (ES)
- Hospital Universitario de Canarias (ES)
- Corresponding author
- Navasa, Miquel
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 133
- Issue
- 3
- Pages
- 818-824
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2012746560
- Cited by
- 709
- References
- 36
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 23 · 2023: 37 · 2022: 28 · 2021: 43 · 2020: 39 · 2019: 42 · 2018: 42 · 2017: 37 · 2016: 34 · 2015: 55 · 2014: 48 · 2013: 31 · 2012: 46
- FWCI
- 30.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Keywords
- spontaneous bacterial peritonitis, primary prophylaxis, norfloxacin, hepatorenal syndrome, liver cirrhosis, survival, renal dysfunction, antibiotic prophylaxis
- MeSH terms
- Aged, Anti-Infective Agents, Double-Blind Method, Female, Hepatorenal Syndrome, Humans, Liver Cirrhosis, Male, Middle Aged, Norfloxacin, Peritonitis, Risk Factors, Survival Analysis, Antibiotic Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
